- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00987701
Perineuraxial Anesthesia Fluid Management and Infant Neurobehaviors (PAFUMIN)
July 26, 2011 updated by: Nanjing Medical University
Correlation Between Perineuraxial Anesthesia Fluid Resuscitation in Cesarean Section and Infant Neurobehaviors
Early change in neurobehavior is strongly associated with the intelligence development of children.
Previous studies reported that cesarean section itself could influence the later development of children.
In addition, neuraxial anesthesia including epidural, spinal and combined spinal epidural anesthesia (CSEA) are the major forms used during cesarean delivery, and these anesthesia techniques will undoubtedly evoke hypotension and corresponding hemodynamic alteration, of which would result in decreasing in umbilical placental insufficiency and fetus hypoxia leading to early abnormality of neurobehaviors in infants.
Fluid management, such as crystalloid and colloid, is the common ones given before or / and after neuraxial anesthesia to prevent or reverse hypotension.
However, it is still unknown whether the perineuraxial anesthesia fluid resuscitation could improve the neurobehavior scorings, and could produce positive effect on later intelligence development.
Herein the investigators hypothesized that effective perineuraxial anesthesia fluid management during cesarean section would prevent the occurrence of hypotension and improve infant's neurobehavior scorings.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
5000
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Jiangsu
-
Nanjing, Jiangsu, China, 210004
- The Affiliated Nanjing Maternity and Child Health Care Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
21 years to 40 years (ADULT)
Accepts Healthy Volunteers
No
Genders Eligible for Study
Female
Description
Inclusion Criteria:
- 21-40 yr
- First time of delivery
- ASA status I-II
- No premature
- No genetic and infectious diseases
- Chinese
Exclusion Criteria:
- < 21 yr
- > 40 yr
- Subjects with cardiac and pulmonary disorders
- Dislocation of placenta
- Pregnant hypertension
- Allergy to local anesthetics
- Unwilling to cooperation
- With significant delivery side effects
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: SINGLE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
ACTIVE_COMPARATOR: Crystalloid resuscitation
Crystalloid (Ringer's lactate) will be delivered before (15min) or after (15min) neuraxial anesthesia
|
Ringer's Lactate 8 ml/kg was given intravenously before or after epidural, spinal or CSEA in cesarean section
Other Names:
|
ACTIVE_COMPARATOR: Colloid resuscitation
Colloid (6% hydroxyethyl starch ) will be delivered before (15min) or after (15min) neuraxial anesthesia
|
Hydroxyethyl starch (6%) was given before or after epidural, spinal or CSEA in cesarean section
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Neurobehavior evaluation with the Assessment of Preterm Infants' Behavior (APIB)
Time Frame: Immediate after birth (0 min)
|
Immediate after birth (0 min)
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Apgar scoring
Time Frame: One min and 5min after birth.
|
One min and 5min after birth.
|
Umbilical-cord gases analysis
Time Frame: At the time baby was born (0min)
|
At the time baby was born (0min)
|
Neonatal sepsis evaluation
Time Frame: One hour after the baby was born
|
One hour after the baby was born
|
Neonatal antibiotic treatment
Time Frame: One hour after the baby was born
|
One hour after the baby was born
|
Incidence of maternal side effects
Time Frame: Analgesia initiation (0min) to successful vaginal delivery (this time encountered alteration with different women)
|
Analgesia initiation (0min) to successful vaginal delivery (this time encountered alteration with different women)
|
Neurobehavior evaluation with the Assessment of Preterm Infants' Behavior (APIB)
Time Frame: 30min after birth
|
30min after birth
|
Neurobehavior evaluation with the Assessment of Preterm Infants' Behavior (APIB)
Time Frame: 1h after birth
|
1h after birth
|
Neurobehavior evaluation with the Assessment of Preterm Infants' Behavior (APIB)
Time Frame: 8h after birth
|
8h after birth
|
Neurobehavior evaluation with the Assessment of Preterm Infants' Behavior (APIB)
Time Frame: 1d after birth
|
1d after birth
|
Neurobehavior evaluation with the Assessment of Preterm Infants' Behavior (APIB)
Time Frame: 1wk after birth
|
1wk after birth
|
Neurobehavior evaluation with the Assessment of Preterm Infants' Behavior (APIB)
Time Frame: 1month after birth
|
1month after birth
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
September 1, 2009
Primary Completion (ACTUAL)
May 1, 2011
Study Completion (ACTUAL)
May 1, 2011
Study Registration Dates
First Submitted
September 30, 2009
First Submitted That Met QC Criteria
September 30, 2009
First Posted (ESTIMATE)
October 1, 2009
Study Record Updates
Last Update Posted (ESTIMATE)
July 27, 2011
Last Update Submitted That Met QC Criteria
July 26, 2011
Last Verified
July 1, 2011
More Information
Terms related to this study
Other Study ID Numbers
- NJMU-0932MZ
- NMUK2190
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Cesarean Section
-
Assiut UniversityNot yet recruitingCesarean Section Complications | Cesarean Section Niche
-
Recep Tayyip Erdogan University Training and Research...CompletedCesarean Section Complications | Cesarean Section; DehiscenceTurkey
-
Ataturk UniversityUnknownCesarean Section Complications | Cesarean Section; Complications, Wound, Dehiscence | Cesarean Section, Repeated | Cesarean, Uterine Scar Thickness | Cesarean, Residual Myometrial ThicknessTurkey
-
Kanuni Sultan Suleyman Training and Research HospitalCompletedCesarean Section Complications | Cesarean Section; DehiscenceTurkey
-
Virginia Commonwealth UniversityRecruitingCesarean SectionUnited States
-
University Tunis El ManarCompleted
-
Federico II UniversityCompletedCesarean SectionItaly
-
Virginia Commonwealth UniversityCompletedCesarean SectionUnited States
-
University of CalgaryCompleted
-
Hallym University Kangnam Sacred Heart HospitalCompletedCesarean SectionKorea, Republic of
Clinical Trials on Ringer's Lactate
-
University of CalgaryNot yet recruitingPost-ERCP Acute Pancreatitis
-
Ottawa Hospital Research InstituteCompleted
-
Paraskevi MatsotaCompleted
-
Ottawa Hospital Research InstituteCompleted
-
University of Sao PauloCompletedHip Replacement ArthroplastyBrazil
-
Alexandria UniversityCompletedNausea and Vomiting, PostoperativeEgypt
-
Innogene Kalbiotech Pte. LtdCompleted
-
MetroHealth Medical CenterCompletedFetus or Neonate Affected by Maternal Epidural Anesthesia During Labor and DeliveryUnited States
-
St. Boniface HospitalUniversity of ManitobaUnknown
-
Innogene Kalbiotech Pte. LtdCompletedLow Cardiac OutputIndonesia